Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Cardiovascular risk factors and prevention: a perspective from develo** countries
KK Teo, T Rafiq - Canadian journal of cardiology, 2021 - Elsevier
By the beginning of the 21st century, cardiovascular disease (CVD) had become the leading
cause of premature mortality and morbidity worldwide, with 80% originating from less …
cause of premature mortality and morbidity worldwide, with 80% originating from less …
Cardiovascular risks associated with gender and aging
JL Rodgers, J Jones, SI Bolleddu… - Journal of …, 2019 - mdpi.com
The aging and elderly population are particularly susceptible to cardiovascular disease. Age
is an independent risk factor for cardiovascular disease (CVD) in adults, but these risks are …
is an independent risk factor for cardiovascular disease (CVD) in adults, but these risks are …
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
Aims Emerging evidence suggests that remnant cholesterol (RC) promotes atherosclerotic
cardiovascular disease (ASCVD). We aimed to estimate RC-related risk beyond low-density …
cardiovascular disease (ASCVD). We aimed to estimate RC-related risk beyond low-density …
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force …
Although there has been substantial improvement in atherosclerotic cardiovascular disease
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …
Chronic kidney disease diagnosis and management: a review
TK Chen, DH Knicely, ME Grams - Jama, 2019 - jamanetwork.com
Importance Chronic kidney disease (CKD) is the 16th leading cause of years of life lost
worldwide. Appropriate screening, diagnosis, and management by primary care clinicians …
worldwide. Appropriate screening, diagnosis, and management by primary care clinicians …
Coronary calcium score and cardiovascular risk
Coronary artery calcium (CAC) is a highly specific feature of coronary atherosclerosis. On
the basis of single-center and multicenter clinical and population-based studies with short …
the basis of single-center and multicenter clinical and population-based studies with short …
Use of Lipoprotein (a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
DP Wilson, TA Jacobson, PH Jones… - Journal of clinical …, 2019 - Elsevier
Abstract Lipoprotein (a)[Lp (a)] is a well-recognized, independent risk factor for
atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in …
atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in …
Effects of stress on the development and progression of cardiovascular disease
Cardiovascular disease remains the leading cause of disease burden globally, which
underlies the continuing need to identify new complementary targets for prevention. Over the …
underlies the continuing need to identify new complementary targets for prevention. Over the …
DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses
Background: The Dietary Approaches to Stop Hypertension (DASH) dietary pattern, which
emphasizes fruit, vegetables, fat-free/low-fat dairy, whole grains, nuts and legumes, and …
emphasizes fruit, vegetables, fat-free/low-fat dairy, whole grains, nuts and legumes, and …
Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients
CDL Johannesen, MB Mortensen, A Langsted… - Journal of the American …, 2021 - jacc.org
Background In cholesterol guidelines, low-density lipoprotein (LDL) cholesterol remains the
primary target while apolipoprotein B (apoB) and non–high-density lipoprotein (non-HDL) …
primary target while apolipoprotein B (apoB) and non–high-density lipoprotein (non-HDL) …